These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 25293440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C, Hallett R, Vora P, Manoranjan B, Mahendram S, Qazi MA, McFarlane N, Subapanditha M, Nolte SM, Singh M, Bakhshinyan D, Garg N, Vijayakumar T, Lach B, Provias JP, Reddy K, Murty NK, Doble BW, Bhatia M, Hassell JA, Singh SK.
    Clin Cancer Res; 2015 Dec 01; 21(23):5324-37. PubMed ID: 26152745
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.
    Ramakrishnan V, Ansell S, Haug J, Grote D, Kimlinger T, Stenson M, Timm M, Wellik L, Halling T, Rajkumar SV, Kumar S.
    Leukemia; 2012 Feb 01; 26(2):340-8. PubMed ID: 21826062
    [Abstract] [Full Text] [Related]

  • 6. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D.
    Stem Cells; 2014 Jan 01; 32(1):301-12. PubMed ID: 24038660
    [Abstract] [Full Text] [Related]

  • 7. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.
    Barat S, Chen X, Cuong Bui K, Bozko P, Götze J, Christgen M, Krech T, Malek NP, Plentz RR.
    Stem Cells Transl Med; 2017 Mar 01; 6(3):819-829. PubMed ID: 28186678
    [Abstract] [Full Text] [Related]

  • 8. Notch promotes radioresistance of glioma stem cells.
    Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA.
    Stem Cells; 2010 Jan 01; 28(1):17-28. PubMed ID: 19921751
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N.
    Oncol Rep; 2012 Oct 01; 28(4):1301-8. PubMed ID: 22895640
    [Abstract] [Full Text] [Related]

  • 10. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G.
    Stem Cells Transl Med; 2012 Aug 01; 1(8):592-603. PubMed ID: 23197865
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
    Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlöw B, Nestor M.
    PLoS One; 2014 Aug 01; 9(4):e94621. PubMed ID: 24760019
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer models.
    Zhang CC, Yan Z, Zong Q, Fang DD, Painter C, Zhang Q, Chen E, Lira ME, John-Baptiste A, Christensen JG.
    Stem Cells Transl Med; 2013 Mar 01; 2(3):233-42. PubMed ID: 23408105
    [Abstract] [Full Text] [Related]

  • 13. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
    Würth R, Pattarozzi A, Gatti M, Bajetto A, Corsaro A, Parodi A, Sirito R, Massollo M, Marini C, Zona G, Fenoglio D, Sambuceti G, Filaci G, Daga A, Barbieri F, Florio T.
    Cell Cycle; 2013 Jan 01; 12(1):145-56. PubMed ID: 23255107
    [Abstract] [Full Text] [Related]

  • 14. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.
    Clin Exp Metastasis; 2011 Dec 01; 28(8):751-63. PubMed ID: 21750907
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.
    J Neurosurg; 2011 Mar 01; 114(3):651-62. PubMed ID: 21054139
    [Abstract] [Full Text] [Related]

  • 16. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
    Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS.
    Mol Cancer; 2006 Dec 02; 5():67. PubMed ID: 17140455
    [Abstract] [Full Text] [Related]

  • 17. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, Tso JL, Liu JY, Konkankit V, Cloughesy TF, Mischel PS, Lane TF, Liau LM, Nelson SF, Tso CL.
    J Neurooncol; 2009 Aug 02; 94(1):1-19. PubMed ID: 19468690
    [Abstract] [Full Text] [Related]

  • 18. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB, Ma RJ, Wang ZK, Yang SJ, Lin XZ, Rong H, Ma Y.
    Mol Cell Biochem; 2011 Mar 02; 349(1-2):149-57. PubMed ID: 21110069
    [Abstract] [Full Text] [Related]

  • 19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC, Chao YJ, Tung HL, Wang HC, Shan YS.
    Cancer; 2014 Sep 01; 120(17):2766-77. PubMed ID: 24839953
    [Abstract] [Full Text] [Related]

  • 20. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.